SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is surging as a community-driven movement that emphasizes organic growth and a 'diamond hand' holding strategy over traditional pump-and-dump tactics. Investors are actively discussing the project's potential to reach significant market milestones, frequently highlighting their dedication to the 'Mauler' brand as they await broader chart integration.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is currently trending due to intense market speculation surrounding its proprietary Perkinamine polymer technology and its integration into major silicon photonics foundries like Tower Semiconductor and GlobalFoundries. The community is actively debating the stock's potential as a critical AI infrastructure play versus concerns about its pre-revenue status and history of insider selling, with many investors closely watching for signs of commercial volume production to justify the company's valuation.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir shares are seeing high volatility as investors weigh a direct presidential endorsement against bearish pressure from notable short-sellers who argue the company's valuation is detached from fundamentals and threatened by emerging AI competitors. The community remains deeply divided, with some betting on a massive short squeeze and institutional accumulation while others warn that the stock is caught in a wider software sector correction.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense market activity and social media buzz driven by speculation around high-profile partnerships, upcoming festival events, and its role in a decentralized music-event ecosystem. The community is sharply divided, with enthusiasts highlighting aggressive accumulation and technical breakout potential, while critics dismiss the asset as a volatile pump-and-dump scheme.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon & Co. is currently trending following an internal probe into sales practices that led to the resignation of its CEO, triggering significant volatility and investor concern regarding the company's future governance and financial outlook. While some market participants are wary of the audit findings, others are actively debating whether this sell-off presents a deep-value opportunity given the company's debt reduction efforts and core product portfolio.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently trending as investors debate its execution and scaling capabilities within the high-performance computing and AI infrastructure sector. The community is actively discussing the company's competitive positioning against peers like Iris Energy and Applied Digital, with significant focus on its power capacity build-out, potential institutional interest, and upcoming site developments.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate the impact of AI agent competition against the company's strong fundamentals and established enterprise role. While the community remains polarized by recent volatility and technical support levels, many are focused on the potential for strategic shifts or buybacks to challenge the prevailing short interest.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is drawing significant attention from investors as it navigates a volatile landscape marked by high-profile contracts, including security for the 2026 FIFA World Cup and major border demining projects. While community members are polarized over the stock's futurebalancing excitement for its aggressive expansion and defense tech partnerships against concerns regarding share dilution and persistent short-seller activitythe stock remains a central topic for those monitoring drone and autonomous systems within the broader defense sector.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is surging to all-time highs as investors pile into the stock ahead of its upcoming Nasdaq-100 index inclusion. The community is intensely debating whether this rapid, AI-driven rallywhich has seen the stock climb over 2,000% in a yearis a sustainable shift in market leadership or an overextended bubble nearing a potential reversal.

Investment Managers Series Trust II - Tradr 2X Long SNDK Daily ETF

Tradr 2X Long SNDK Daily ETF

Investors are actively trading SNXX as a leveraged play to capitalize on the rapid momentum and high volatility of its underlying flash storage stock. The community remains focused on managing risk through short-term swing trades and hedging strategies while debating the impact of increased leverage on overall sector performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

10x Genomics (NASDAQ:TXG) Hits New 52-Week High on Analyst Upgrade

10x Genomics (NASDAQ:TXG) Hits New 12-Month High Following Analyst Upgrade...

Citigroup Issues Positive Forecast for 10x Genomics (NASDAQ:TXG) Stock Price

Citigroup lifted their price target on shares of 10x Genomics from $18.00 to $24.00 and gave the company a "neutral" rating in a research report on Tuesday...

10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout

William Blair upgrades 10x Genomics, citing AI-driven data demand, improving execution and Xenium validation as key growth drivers.read more...

10x Genomics (NASDAQ:TXG) Shares Gap Up Following Analyst Upgrade

10x Genomics (NASDAQ:TXG) Shares Gap Up on Analyst Upgrade...

10x Genomics (NASDAQ:TXG) Upgraded to Outperform at William Blair

William Blair raised 10x Genomics from a "market perform" rating to an "outperform" rating in a research note on Tuesday...

JPMorgan Chase & Co. Raises Position in 10x Genomics $TXG

JPMorgan Chase & Co. grew its position in shares of 10x Genomics (NASDAQ:TXG - Free Report) by 777.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,073,865 shares of the company's stock after buying a...

Tempus AI Reinforces Market Position With Collaborations in 2026

TEM expands 2026 reach via strategic collaborations, boosting oncology, diagnostics and AI-driven insights to enhance care and drug development.

Insider Selling: 10x Genomics (NASDAQ:TXG) CEO Sells 5,000 Shares of Stock

10x Genomics (NASDAQ:TXG - Get Free Report) CEO Serge Saxonov sold 5,000 shares of the company's stock in a transaction on Tuesday, March 24th. The shares were sold at an average price of $19.52, for a total transaction of $97,600.00. Following the completion of the sale, the chief executive...

10x Genomics (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages

10x Genomics (NASDAQ:TXG - Get Free Report) has earned a consensus recommendation of "Hold" from the sixteen ratings firms that are currently covering the company, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation an...

10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,000 Shares

10x Genomics (NASDAQ:TXG - Get Free Report) CEO Serge Saxonov sold 10,000 shares of the stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $19.13, for a total value of $191,300.00. Following the transaction, the chief executive officer owned 1,177,273 shares of...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

TXG
10x Genomics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TXG News

TXG10x Genomics Inc - Ordinary Shares - Class A